Frédéric Garzoni is a biotech innovator and scientific leader with over 20 years of experience spanning research, entrepreneurship, and executive leadership.

He co-founded a UK-based biotech company, serving as CEO and later CSO, where he raised over £7M in funding and led the development of groundbreaking vaccine candidates using a novel platform he co-invented. Frédéric is an inventor of multiple international patents and has published in top journals including Nature, Science, and Nature Communications.

Frédéric has been named as Franco-British Young Leader, and he actively contributes to international science diplomacy and policies, and serves on the Health Committee of the French Embassy in the UK.